FNDC5 and chronic kidney disease: Compared with normal subjects, the irisin levels in CKD patients were lower (0.6199±0.056; 95% CI 0.5072–0.7326) and significantly decreased (58.59%; 95% CI 47.9%–69.2%, p<0.0001) (Fig. 1A).